Arca
Skip to content
Tools
Tools

-buvir

A hepatitis C NS5B polymerase inhibitor.

  • Drugs ending in -buvir: 13
  • Approved somewhere: 2
  • With a US drug page: 1

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-buvir
Class
Hepatitis C drugs that block the viral NS5B polymerase
Sub-stem of
vir: Antivirals
Most common targets
NS5B (12)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -buvir, matched by spelling; those with a US drug page link to it.
Acts on
SofosbuvirApprovedNS5BRNA-directed RNA polymerase inhibitor
DasabuvirApprovedNS5BRNA-directed RNA polymerase inhibitor
BeclabuvirPhase 3NS5BRNA-directed RNA polymerase negative allosteric modulator
BemnifosbuvirPhase 3โ€”โ€”
DeleobuvirPhase 3NS5BRNA-directed RNA polymerase inhibitor
AdafosbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
FilibuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
LomibuvirPhase 2NS5BRNA-directed RNA polymerase negative allosteric modulator
NesbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
RadalbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
SetrobuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
TegobuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
UprifosbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.